{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:59:52Z","timestamp":1770998392242,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer New York","isbn-type":[{"value":"9781493986293","type":"print"},{"value":"9781493986309","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-8630-9_22","type":"book-chapter","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T13:28:03Z","timestamp":1532352483000},"page":"371-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Designing Natural Product Hybrids Bearing Triple Antiplatelet Profile and Evaluating Their Human Plasma Stability"],"prefix":"10.1007","author":[{"given":"Antonis","family":"Tsiailanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tsoumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenios K.","family":"Stylos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"Chatziathanasiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahsin F.","family":"Kellici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mavromoustakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros D.","family":"Tselepis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas G.","family":"Tzakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"issue":"9","key":"22_CR1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2174\/1381612823666170124141806","volume":"23","author":"ME Tsoumani","year":"2017","unstructured":"Tsoumani ME, Tselepis AD (2017) Antiplatelet agents and anticoagulants: from pharmacology to clinical practice. Curr Pharm Des 23(9):1279\u20131293. https:\/\/doi.org\/10.2174\/1381612823666170124141806","journal-title":"Curr Pharm Des"},{"issue":"23","key":"22_CR2","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32(23):2999\u20133054. https:\/\/doi.org\/10.1093\/eurheartj\/ehr236","journal-title":"Eur Heart J"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2147\/TCRM.S55469","volume":"11","author":"P Diehl","year":"2015","unstructured":"Diehl P, Bode C, Duerschmied D (2015) Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis. Ther Clin Risk Manag 11:1133\u20131138. https:\/\/doi.org\/10.2147\/TCRM.S55469","journal-title":"Ther Clin Risk Manag"},{"issue":"16","key":"22_CR4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s40265-017-0806-1","volume":"77","author":"F Costa","year":"2017","unstructured":"Costa F, Windecker S, Valgimigli M (2017) Dual antiplatelet therapy duration: reconciling the inconsistencies. Drugs 77(16):1733\u20131754. https:\/\/doi.org\/10.1007\/s40265-017-0806-1","journal-title":"Drugs"},{"issue":"11","key":"22_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.amjmed.2017.03.057","volume":"130","author":"N Agarwal","year":"2017","unstructured":"Agarwal N, Jain A, Mahmoud AN et al (2017) Safety and efficacy of dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention. Am J Med 130(11):1280\u20131289. https:\/\/doi.org\/10.1016\/j.amjmed.2017.03.057","journal-title":"Am J Med"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2015.03.049","volume":"185","author":"IC Moschonas","year":"2015","unstructured":"Moschonas IC, Goudevenos JA, Tselepis AD (2015) Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives. Int J Cardiol 185:9\u201318. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.049","journal-title":"Int J Cardiol"},{"issue":"22","key":"22_CR7","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1021\/acs.jafc.6b00544","volume":"64","author":"VG Kontogianni","year":"2016","unstructured":"Kontogianni VG, Tsoumani ME, Kellici TF et al (2016) Deconvoluting the dual antiplatelet activity of a plant extract. J Agric Food Chem 64(22):4511\u20134521. https:\/\/doi.org\/10.1021\/acs.jafc.6b00544","journal-title":"J Agric Food Chem"},{"issue":"8878","key":"22_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0140-6736(93)92876-U","volume":"342","author":"MG Hertog","year":"1993","unstructured":"Hertog MG, Feskens EJ, Hollman PC et al (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342(8878):1007\u20131011","journal-title":"Lancet"},{"issue":"2","key":"22_CR9","first-page":"179","volume":"1","author":"I Palomo","year":"2008","unstructured":"Palomo I, Toro C, Alarcon M (2008) The role of platelets in the pathophysiology of atherosclerosis (review). Mol Med Rep 1(2):179\u2013184","journal-title":"Mol Med Rep"},{"issue":"1 Suppl","key":"22_CR10","doi-asserted-by":"publisher","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","volume":"81","author":"C Manach","year":"2005","unstructured":"Manach C, Williamson G, Morand C et al (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 Suppl):230S\u2013242S","journal-title":"Am J Clin Nutr"},{"issue":"11 Pt A","key":"22_CR11","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.bbagen.2017.08.018","volume":"1861","author":"E Stylos","year":"2017","unstructured":"Stylos E, Chatziathanasiadou MV, Tsiailanis A et al (2017) Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation. Biochim Biophys Acta 1861(11 Pt A):2609\u20132618. https:\/\/doi.org\/10.1016\/j.bbagen.2017.08.018","journal-title":"Biochim Biophys Acta"},{"key":"22_CR12","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2015\u20132 (2015) Maestro, version 10.5, Schr\u00f6dinger, LLC, New York, NY","DOI":"10.1063\/pt.5.031026"},{"key":"22_CR13","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2015\u20132 (2015) LigPrep, version 3.4, Schr\u00f6dinger, LLC, New York, NY","DOI":"10.1063\/pt.5.031026"},{"issue":"1","key":"22_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder E, Damm W, Maple J et al (2016) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 12(1):281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864","journal-title":"J Chem Theory Comput"},{"key":"22_CR15","unstructured":"Small-Molecule Drug Discovery Suite 2015\u20132 (2015) QikProp, version 4.4, Schr\u00f6dinger, LLC, New York, NY"},{"key":"22_CR16","doi-asserted-by":"crossref","unstructured":"Schr\u00f6dinger Release 2015\u20132 (2015) Canvas, version 2.4, Schr\u00f6dinger, LLC, New York, NY","DOI":"10.1063\/pt.5.031026"},{"issue":"1\u20132","key":"22_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2005.03.022","volume":"297","author":"L Di","year":"2005","unstructured":"Di L, Kerns EH, Hong Y et al (2005) Development and application of high throughput plasma stability assay for drug discovery. Int J Pharm 297(1\u20132):110\u2013119. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.03.022","journal-title":"Int J Pharm"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/B978-012369520-8.50013-9","volume-title":"Drug-like properties: concepts, structure design and methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L (2008) Chapter 12 - plasma stability. In: Drug-like properties: concepts, structure design and methods. Academic Press, San Diego, CA, pp 169\u2013177. https:\/\/doi.org\/10.1016\/B978-012369520-8.50013-9"},{"issue":"6","key":"22_CR19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jth.12231","volume":"11","author":"M. Cattaneo","year":"2013","unstructured":"Cattaneo M, Cerletti C, Harrison P et al (2013) Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC\/ISTH. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.12231","journal-title":"Journal of Thrombosis and Haemostasis"}],"container-title":["Methods in Molecular Biology","Rational Drug Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8630-9_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:36:17Z","timestamp":1751758577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8630-9_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493986293","9781493986309"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8630-9_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}